References
- Frommer D A, Kulig K W, Marx J A, Rumack B. Tricyclic antidepressant overdose. JAMA 1987; 257: 521–526
- Scholz H. Inotropic drugs and their mechanisms of action. J Am Coll Cardiol 1984; 4: 389–397
- Ruddy J M, Seymour J L, Anderson N G. Management of tricyclic antidepressant ingestion in children with special reference to the use of glucagon. Med J Aust 1972; 1: 630–633
- Kosinski E J, Stein N, Malindzak GS JR, Boone E. Glucagon and propranolol (Inderal) toxicity. N Engl J Med 1971; 285: 1325
- Pentel P R, Benowitz N L. Tricyclic antidepressant poisoning. Management of arrhythmias. Med Toxicol 1986; 1: 101–121
- Wolf L R, Spadafora M P, Otten E J. Use of amrinone and glucagon in a case of calcium channel blocker overdose. Ann Emerg Med 1993; 22: 1225–1228
- Doyon S, Roberts J R. The use of glucagon in a case of calcium channel blocker overdose. Ann Emerg Med 1993; 22: 1229–1233
- Pollack C V. Utility of glucagon in the emergency department. J Emerg Med 1993; 11: 195–205
- Kulig K. Initial management of ingestions of toxic substances. N Engl J Med 1992; 326: 1677–1681
- Farah A E. Glucagon and the circulation. Pharmacol Rev 1983; 35: 181–217
- Prasad K. Electrophysiologic effects of glucagon on human cardiac muscle. Clin Pharmacol Ther 1975; 18: 22–30
- Zaloga G P. Cardiovascular emergencies. Glucagon in Acute Medicine, J Picazo. Kluwer Academic Publishers, Dordrecht 1993; 11–25
- Prasad K. Use of glucagon in the treatment of quinidine toxicity in the heart. Cardiovasc Res 1977; 11: 55–63
- Denney D L, Daniell H B. Glucagon-induced cardiac effects following normal and toxic doses of ouabain. Arch Int Pharmacodyn Ther 1971; 191: 111–119
- Sabatier J, Pouyet T, Shelvey G, Cavero I. Antagonistic effects of epinephrine, glucagon and methylatropine but not calcium chloride against atrio-ventricular conduction disturbances produced by high doses of diltiazem, in conscious dogs. Fundam Clin Pharmacol 1991; 5: 93–106